Interferon-α restores normal β1 integrin-mediated inhibition of hematopoietic progenitor proliferation by the marrow microenvironment in chronic myelogenous leukemia

Blood

Volumn 87, Issue 9, 1996, Pages 3883-3891

  Bhatia, Ravi ^a,b   McCarthy, James B ^a   Verfaillie, Catherine M ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIV OF MINNESOTA HOSP AND CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; INTEGRIN;

ARTICLE; BONE MARROW; CELL PROLIFERATION; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; STROMA;

EID: 0029888021     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.9.3883.bloodjournal8793883     Document Type: Article

References (56)

1. Rowley JD: A new consistent chromosome abnormality in chronic myelogenous leukemia. Nature 243:209, 1973
2. DeKlein A, Van Kessel AG, Grosveld G, Bartram CR, Hagemeijer A, Bostooma D, Spurr NK, Heisterkamp N, Groffen J, Stephenson JR: A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukemia. Nature 300:765, 1982
3. Cashman J, Eaves AC, Eaves CJ: Regulated proliferation of primitive hematopoietic progenitors in long-term human marrow cultures. Blood 66:1002, 1985
4. Eaves AC, Cashman JD, Gaboury LA, Kalousek DK, Eaves CJ: Unregulated proliferation of primitive chronic myelogenous leukemia progenitors in the presence of normal marrow adherent cells. Proc Natl Acad Sci USA 83-5306, 1986
5. Teixido J, Hemler ME, Greenberger JS, Anklesaria P: Role of β1 and β2 integrins in the adhesion of human CD34+ stem cells to bone marrow stroma. J Clin Invest 90:358, 1992
6. Verfaillie CM, McCarthy JB, McGlave PB: Differentiation of primitive human multipotent hematopoietic progenitors into single lineage clonogenic progenitors is accompanied by alterations in their adhesion to fibronectin. J Exp Med 174:693, 1991
7. Miyake K, Weissman IL, Greenberger JS, Kincade PW: Evidence for a role of the integrin VLA-4 in lympho-hemopoeisis. J Exp Med 173:599, 1991
8. Simmons PJ, Masinovsky B, Longenecker BM, Berenson R, Torok-Storb B, Galatin WM: Vascular cell adhesion molecule 1 is expressed by bone marrow stromal cells and mediates binding of hematopoietic cells. Blood 80:388, 1992
9. Hurley RW, McCarthy JB, Verfaillie CM: Direct adhesion to bone marrow stroma via fibronectin receptors inhibits hematopoietic progenitor proliferation. J Clin Invest 96:511, 1995
10. Hurley RW, McCarthy JB, Wayner EA, Verfaillie CM: Monoclonal antibody induced clustering of the alpha-4 integrin inhibits hematopoietic progenitor proliferation. Exp Hematol 22:767, 1994 (abstr)
11. Gordon MY, Dowding CR, Riley GP, Goldman JM, Greaves MF: Altered adhesive interactions with marrow stroma of haematopoietic progenitor cells in chronic myeloid leukaemia. Nature 328:342, 1987
12. Verfaillie CM, McCarthy JB, McGlave PB: Mechanisms underlying abnormal trafficking of malignant progenitors in chronic myelogenous leukemia: Decreased adhesion to stroma and fibronectin but increased adhesion to the basement membrane components laminin and collagen type IV. J Clin Invest 90:1232, 1992
13. Talpaz M, Kantarjian HM, Kurzrock R, Trujillo JM, Gutterman JU: Interferon-α produces sustained cytogenetic responses in chronic myelogenous leukemia Philadelphia chromosome positive patients. Ann Intern Med 114:532, 1991
14. Kantarjian HM, Smith TL, O'Brien S, Beran M, Pierce S, Talpaz M: Prolonged survival in chronic myelogenous leukemia after cytogenetic response to interferon-α therapy. Ann Intern Med 122:254, 1995
15. Dowding C, Guo A-P, Maisin D, Gordon MY, Goldman JM: The effects of interferon-α on the proliferation of CML progenitor cells are not related to the precise position of the M-BCR breakpoint. Br J Haematol 77:165, 1991
16. Dowding C, Guo A-P, Osterholz J, Sickowski M, Goldman J, Gordon M: Interferon-α overrides the deficient adhesion of chronic myelogenous leukemia primitive progenitor cells to bone marrow stromal cells. Blood 78:499, 1991
17. Upadhyaya G, Guba SC, Sih SA, Feinberg AP, Talpaz M, Kantarjian HM, Deisseroth AB, Emerson SG: Interferon-alpha restores the deficient expression of the cytoadhesion molecule Lymphocyte Function Antigen-3 by chronic myelogenous leukemia progenitor cells. J Clin Invest 88:2131, 1991
18. Bhatia R, Wayner EA, McGlave PB, Verfaillie CM: Interferon-α restores normal adhesion of chronic myelogenous leukemia hematopoietic progenitors to bone marrow stroma by correcting impaired β1 integrin receptor function. J Clin Invest 94:384, 1994
19. Bhatia R, McGlave PB, Verfaillie CM: Treatment of marrow stroma with interferon-α restores normal β1 integrin dependent adhesion of chronic myelogenous leukemia hematopoietic progenitors; Role of MIP-1alpha. J Clin Invest 96:931, 1995
20. Brandt J, Srour E, van Besien K, Bridell RA, Hoffman R: Cytokine-dependent long term culture of highly enriched hematopoietic progenitor cells from human bone marrow. J Clin Invest 86:932, 1990
21. Verfaillie C, McGlave PB: Leukemia inhibitory factor/human interleukin for DA cells: A growth factor that stimulates the in vitro development of multipotential human hemopoietic progenitors. Blood 77:263, 1991
22. Verfaillie C, Blakholmer K, McGlave P: Purified primitive human hematopoietic progenitors with long term in vitro repopulating capacity adhere selectively to irradiated bone marrow stroma. J Exp Med 179:509, 1990
23. Berenson RJ, Andrews RG, Bensinger WI, Kalamasz D, Knitter G, Buckner CD, Bernstein ID: Antigen CD34+ marrow cells engraft lethally irradiated baboons. J Clin Invest 81:951, 1988
24. Verfaillie CM, Miller WJ, Boylan K, McGlave PB: Selection of benign primitive hematopoietic progenitors in chronic myelogenous leukemia on the basis of HLA-DR expression. Blood 79:1003, 1992
25. McCarthy JB, Haugen ST, Furcht LT: Human fibronectin contains distinct adhesion and motility-promoting domains for metastatic melanoma cells. J Cell Biol 102:179, 1986
26. Verfaillie CM: Soluble factor(s) produced by human bone marrow stroma increase cytokine-induced proliferation and maturation of primitive hematopoietic progenitors while preventing their terminal differentiation. Blood 82:2045, 1993
27. Davis LS, Oppenheimer-Marks N, Bednarczyk JL, McIntyre BW. Lipsky PE: Fibronectin promotes proliferation of naive and memory T cells by signaling through both the VLA-4 and VLA-5 integrin molecules. J Immunol 145:785, 1990
28. 1c. Science 269:1570, 1995
29. Adams JC, Watt FM: Fibronectin inhibits the terminal differentiation of human keratinocytes. Nature 340:307, 1989
30. Zhang Z, Vuori K, Reed JC, Ruoslahti E: The α5β1 integrin supports survival of cells on fibronectin and upregulates Bcl-2 expression. Proc Natl Acad Sci USA 92:6161, 1995
31. Burridge K, Fath K, Kelly T, Nuckolls G, Turner C: Focal adhesions: Transmembrane junctions between the extracellular matrix and the cytoskeleton. Ann Rev Cell Biol 4:487, 1988
32. Clark EA, Brugge JS: Integrins and signal transduction pathways: The road taken. Science 268:233, 1995
33. Hynes RO: Integrins: Versatility, modulation and signaling in cell adhesion. Cell 69:11, 1992
34. Kornberg L, Earp HS, Parsons JT, Schaller M, Juliano RL: Cell adhesion or integrin clustering increases phosphoryiation of focal adhesion associated tyrosine kinase. J Biol Chem 267:23439, 1992
35. Schlaepfer DD, Hanks SK, Hunter T, van der Geer P: Integrin-mediated signal transduction linked to Ras pathway by GRB2 binding to focal adhesion kinase. Nature 372:786, 1994
36. Guinebault C, Payrastre B, Racaud-Sultan C, Mazarguil H, Breton M, Mauco G, Plantavid M, Chap H: Integrin-dependent transIocation of phosphoinositide 3-kinase to the cyloskeleton involves specific interactions of p85a with actin filaments and focal adhesion kinase. J Cell Biol 129:831, 1995
37. Talpaz M, Estrov Z, Kantarjian H, Ku S, Foteh A, Kurzrock R: Persistence of dormant leukemic progenitors during interferoninduced remission in chronic myelogenous leukemia. J Clin Invest 94:1383, 1994
38. Cashman JD, Eaves AC, Raines EW, Ross R, Eaves CJ: Mechanisms that regulate the cell cycle status of very primitive hematopoietic cells in long-term human marrow cultures. I. Stimulatory role of a variety of mesenchymal cell activators and inhibitory role of TGF-β. Blood 75:96, 1990
39. Massague J, Cheifitz A, Boyd FT, Andres JL: TGF-β receptors and TGF-β binding proteoglycans: Recent progress in identifying their functional properties. Ann NY Acad Sci 593:59, 1990
40. Broxmeyer HE, Sherry B, Lu L, Cooper S, Oh K-O, Tekamp-Olson P, Kwon BS, Cerami A: Enhancing and suppressing effects of recombinant murine macrophage inflammatory protein on colony formation in vitro by bone marrow myeloid progenitor cells. Blood 76:1110, 1990
41. Tanaka Y, Adams DH, Hubscher S, Hirano H, Siebenlist U, Shaw S: T cell adhesion induced by proteoglycan immobilized cytokine MIP 1β. Nature 361-79, 1993
42. Evans SS, Collea RP, Appenheimer MM, Golnick SO: Interferon-α induces the expression of L-Selectin homing receptors in human B lymphoid cells. J Cell Biol 123:1889, 1993
43. Faull FJ, Kovach NL, Harlan JM, Ginsberg MH: Affinity modulation of integrin α5β1: Regulation of the functional response by soluble fibronectin. J Cell Biol 121:155, 1993
44. Lundell BI, McCarthy JB, Kovach NL, Verfaillie CM: Adhesion to fibronectin induced by the activating anti-integrin-β1 antibody, 8A2, restores adhesion mediated inhibition of CML progenitor proliferation Blood 84:150a, 1994 (abstr, suppl 1)
45. Lugo TG, Pendergast AM, Muller AJ, Witte ON: Tyrosine kinase activity and transformation potency of bcr-abl oncogene products. Science 247:1079, 1990
46. McWhirter JR, Wang JYJ: An actin-binding function contributes to transformation by the Bcr-abl oncoprotein of Philadelphia chromosome-positive human leukemias. EMBO J 12:1533, 1993
47. Gotoh A, Miyazawa K, Ohyashiki K, Tauchi T, Boswell HS, Broxmeyer HE, Toyama K: Tyrosine Phosphorylation and Kinase Activation of Focal Adhesion Kinase (p125FAK) in Human PhPositive leukemia Cell Lines. Blood 82:104a, 1993 (abstr, suppl 1)
48. BCR/ABL. J Biol Chem 270:5039, 1995
49. Skorski T, Kanakaraj P, Ku D-H, Nieberowska-Skorska M, Canaani E, Zon G, Perussia B, Calabretta B: Negative regulation of p120GAP GTPase promoting activity by p210bcr/abl: Implication for RAS-dependent Philadelphia chromosome positive cell growth J ExpMed 179:1855, 1994
50. Horvath AR, Elmore MA, Kellie S: Differential tyrosine specific phosphorytation of integrin in Rons sarcoma transformed cells with differing transformed phenotype. Oncogene 5:1349, 1990
51. Johansson MW, Larsson E, Luning B, Pasquale EB, Ruoslahti E: Altered localization and cytoplasmic domain-binding properties of tyrosine-phosphorylated β1 integrin. J Cell Biol 126:1299, 1994
52. Pendergast AM, Quilliam LA, Cripe LD, Bassing CH, Dai Z, Li N, Schlessinger J, Gishisky ML: BCR-ABL induced oncogenesis is mediated by direct interaction with the SH2 domain of the GRB-2 adapter protein Cell 75:175, 1993
53. Tauchi T, Boswell HS, Leibowitz D, Broxmeyer HE: Coupling between p210bcr-abl and Shc and Grb-2 adapter proteins in hematopoietic cells permits growth factor independent link to Ras activation pathway. J Exp Med 179:167, 1994
54. Keating A, Wang X-H, Laraya P: α-Interferon suppresses transcription of bcr-abl in Ph+ chronic myelogenous leukemia progenitor cells. Exp Hematol 21:1073, 1993 (abstr)
55. David M, Romero G, Zhang ZY, Dixon JE, Lamer AC: In vitro activation of the transcription factor ISGF3 by interferon alpha involves a membrane associated tyrosine phosphatase and tyrosine kinase. J Biol Chem 268:6593, 1993
56. Pfeffer LM, Landsberger FR: Interferon-alpha modulates the plasma membrane-cytoskeletal complex of human lymphoblastoid cells sensitive to the antiproliferative action of interferon-alpha. J Interferon Res 10:91, 1990